Procurement Footprint
Astrazeneca — public-sector procurement footprint
From open OCDS records, AqlData resolved 314 name-spelling variants of Astrazeneca into one identity (314 legal entities) and mapped its public-sector footprint: 27 countries, ~$10.9B in awarded value (FX-approx, indicative), across 9,427+ tracked contracts (2002-05-24 – 2026-05-22).
27
countries
$10.9B
awarded value *
9,427+
tracked contracts
1,340
public buyers
* ok-quality, FX-converted contracts only (no_value / no_fx / outlier records excluded). Indicative at current spot FX — not historical rates.
Geographic reach
| Country | Contracts | ~Value ($M) |
|---|---|---|
| GB | 50 | 2,164.2 |
| EU | 195 | 2,163.3 |
| IT | 1,514 | 2,095.4 |
| ES | 395 | 1,303.9 |
| SE | 42 | 818.7 |
| FI | 18 | 504.8 |
| + 21 more countries | in full report | — |
Top public buyers
| Buyer | Country | Contracts |
|---|---|---|
| Dirección General de la Salud | UY | 1,299 |
| Unidade Local de Saúde do Norte Alentejano, E. P. E. | PT | 334 |
| Instituto Português de Oncologia do Porto Francisco Ge | PT | 281 |
| + 1,337 more buyers — every agency, contract-level | — | in full report |
Activity over time
2015301
2016329
2017333
2018597
2019762
2020840
2021611
20221,367
20231,089
20241,464
2025478
2026103
The full due-diligence report
All 27 countries, every one of 1,340 public buyers at the contract level, single-customer revenue concentration, the top-5 buyer split and the buyer-level competitor map — the complete Astrazeneca due-diligence brief, delivered within 24 hours.
Order this report — $499Request a worked sample